Hospitalization costs for heart failure in people with type 2 diabetes: Cost-effectiveness of its prevention measured by a simulated preventive treatment
Objectives: To estimate the cost-consequence of interventions to prevent hospitalizations for heart failure (HF) in people with type 2 diabetes. Methods: In HF events (63) from type 2 diabetes-related hospitalizations (N = 462) recorded in an Argentine hospital (March 2004April 2005), we verified 1)...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2011
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/83925 |
| Aporte de: |
| id |
I19-R120-10915-83925 |
|---|---|
| record_format |
dspace |
| institution |
Universidad Nacional de La Plata |
| institution_str |
I-19 |
| repository_str |
R-120 |
| collection |
SEDICI (UNLP) |
| language |
Inglés |
| topic |
Ciencias Médicas cost analysis diabetes heart failure prevention and control |
| spellingShingle |
Ciencias Médicas cost analysis diabetes heart failure prevention and control Caporale, Joaquín Enzo Elgart, Jorge Federico Pfirter, Guillermina Martínez, Pablo Vies, Gloria Insa, Jorge T. Gagliardino, Juan José Hospitalization costs for heart failure in people with type 2 diabetes: Cost-effectiveness of its prevention measured by a simulated preventive treatment |
| topic_facet |
Ciencias Médicas cost analysis diabetes heart failure prevention and control |
| description |
Objectives: To estimate the cost-consequence of interventions to prevent hospitalizations for heart failure (HF) in people with type 2 diabetes. Methods: In HF events (63) from type 2 diabetes-related hospitalizations (N = 462) recorded in an Argentine hospital (March 2004April 2005), we verified 1) the presence of one metabolic HF predictor (glycosylated hemoglobin [HbA1c] value) before hospitalization; and 2) in a simulation model, the resources needed for its prevention controlling such predictor during 6 months before and after the event. Sensitivity analysis of HF risk reduction, hospitalization cost, and cost of different treatments to achieve HbA1c 7% or less was performed with a Monte Carlo simulation (10,000 iterations). Results: HF represented 14% of hospitalizations, with a 44% rehospitalization rate for the same cause. Due to the total estimated cost for an HF hospitalization event was $437.31, the prevention attained using our simulated treatment was $2326.51. The number needed to treat to prevent an HF event under any of the proposed alternatives to reduce HbA1c would be 3.57 (95% confidence interval 2.0016.67). The additional cost of the simulated treatment versus the real one oscillates between $6423.91 and $8455.68. Conclusions: HbA1c control to reduce the number of HF events would be economically beneficial for health care payers. |
| format |
Articulo Articulo |
| author |
Caporale, Joaquín Enzo Elgart, Jorge Federico Pfirter, Guillermina Martínez, Pablo Vies, Gloria Insa, Jorge T. Gagliardino, Juan José |
| author_facet |
Caporale, Joaquín Enzo Elgart, Jorge Federico Pfirter, Guillermina Martínez, Pablo Vies, Gloria Insa, Jorge T. Gagliardino, Juan José |
| author_sort |
Caporale, Joaquín Enzo |
| title |
Hospitalization costs for heart failure in people with type 2 diabetes: Cost-effectiveness of its prevention measured by a simulated preventive treatment |
| title_short |
Hospitalization costs for heart failure in people with type 2 diabetes: Cost-effectiveness of its prevention measured by a simulated preventive treatment |
| title_full |
Hospitalization costs for heart failure in people with type 2 diabetes: Cost-effectiveness of its prevention measured by a simulated preventive treatment |
| title_fullStr |
Hospitalization costs for heart failure in people with type 2 diabetes: Cost-effectiveness of its prevention measured by a simulated preventive treatment |
| title_full_unstemmed |
Hospitalization costs for heart failure in people with type 2 diabetes: Cost-effectiveness of its prevention measured by a simulated preventive treatment |
| title_sort |
hospitalization costs for heart failure in people with type 2 diabetes: cost-effectiveness of its prevention measured by a simulated preventive treatment |
| publishDate |
2011 |
| url |
http://sedici.unlp.edu.ar/handle/10915/83925 |
| work_keys_str_mv |
AT caporalejoaquinenzo hospitalizationcostsforheartfailureinpeoplewithtype2diabetescosteffectivenessofitspreventionmeasuredbyasimulatedpreventivetreatment AT elgartjorgefederico hospitalizationcostsforheartfailureinpeoplewithtype2diabetescosteffectivenessofitspreventionmeasuredbyasimulatedpreventivetreatment AT pfirterguillermina hospitalizationcostsforheartfailureinpeoplewithtype2diabetescosteffectivenessofitspreventionmeasuredbyasimulatedpreventivetreatment AT martinezpablo hospitalizationcostsforheartfailureinpeoplewithtype2diabetescosteffectivenessofitspreventionmeasuredbyasimulatedpreventivetreatment AT viesgloria hospitalizationcostsforheartfailureinpeoplewithtype2diabetescosteffectivenessofitspreventionmeasuredbyasimulatedpreventivetreatment AT insajorget hospitalizationcostsforheartfailureinpeoplewithtype2diabetescosteffectivenessofitspreventionmeasuredbyasimulatedpreventivetreatment AT gagliardinojuanjose hospitalizationcostsforheartfailureinpeoplewithtype2diabetescosteffectivenessofitspreventionmeasuredbyasimulatedpreventivetreatment |
| bdutipo_str |
Repositorios |
| _version_ |
1764820488192786435 |